AJANTA PHARMA share price has plunged 10% and is presently trading at Rs 2,800.0.
Meanwhile, the BSE HEALTHCARE index is at 43,973.0 (up 0.5%).
Among the top losers in the BSE HEALTHCARE index today are J.B.Chemicals (down 1.4%) and SUVEN PHARMACEUTICALS (down 0.9%).
ASTER DM HEALTHCARE (up 3.8%) and ALEMBIC PHARMA (up 2.0%) are among the top gainers today.
Over the last one year, AJANTA PHARMA has moved up from Rs 1,664.7 to Rs 2,800.0, registering a gain of Rs 1,135.4 (up 68.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,973.0, registering a gain of 54.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 169.5%), SUVEN PHARMACEUTICALS (up 106.6%) and Lupin (up 95.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 83,359.2 (up 0.5%).
The top gainers among the BSE Sensex today are NTPC (up 2.8%) and HCl Tech. (up 1.7%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.
In the meantime, NSE Nifty is at 25,487.1 (up 0.4%). NTPC and LTIMINDTREE are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,359.2, registering a gain of 15,762.3 points (up 23.3%).
AJANTA PHARMA net profit grew 18.1% YoY to Rs 2,458 million for the quarter ended June 2024, compared to a profit of Rs 2,081 million a year ago. Net sales rose 12.1% to Rs 11,449 million during the period as against Rs 10,210 million in April-June 2023.
For the year ended March 2024, AJANTA PHARMA reported 38.8% increase in net profit to Rs 8,162 million compared to net profit of Rs 5,880 million during FY23. Revenue of the company grew 12.5% to Rs 42,087 million during FY24.
The current Price to earnings ratio of AJANTA PHARMA, based on rolling 12 month earnings, stands at 41.0.
Equitymaster requests your view! Post a comment on "AJANTA PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!